Log in

NYSE:GMRE - Global Medical REIT Stock Price, Forecast & News

-0.15 (-1.15 %)
(As of 12/13/2019 09:16 AM ET)
Today's Range
Now: $12.85
50-Day Range
MA: $12.87
52-Week Range
Now: $12.85
Volume1.12 million shs
Average Volume537,105 shs
Market Capitalization$473.78 million
P/E Ratio16.47
Dividend Yield6.15%
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Industry, Sector and Symbol

Industry Real estate investment trusts



Sales & Book Value

Annual Sales$53.19 million
Cash Flow$1.47 per share
Book Value$10.08 per share


Net Income$13.49 million


Market Cap$473.78 million
Next Earnings Date3/5/2020 (Estimated)

Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.

Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a -- dividend on Monday, September 16th. Investors of record on Wednesday, September 25th will be given a dividend of $0.20 per share on Thursday, October 10th. This represents a yield of 7.1%. The ex-dividend date is Tuesday, September 24th. View Global Medical REIT's Dividend History.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc (NYSE:GMRE) issued its earnings results on Wednesday, November, 6th. The company reported $0.02 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.19 by $0.17. The company earned $18.20 million during the quarter, compared to analyst estimates of $17.68 million. Global Medical REIT had a net margin of 23.42% and a return on equity of 5.49%. View Global Medical REIT's Earnings History.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Global Medical REIT.

What price target have analysts set for GMRE?

4 brokers have issued 12-month price objectives for Global Medical REIT's stock. Their forecasts range from $9.03 to $11.00. On average, they expect Global Medical REIT's share price to reach $10.51 in the next twelve months. This suggests that the stock has a possible downside of 18.2%. View Analyst Price Targets for Global Medical REIT.

What is the consensus analysts' recommendation for Global Medical REIT?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.

What are Wall Street analysts saying about Global Medical REIT stock?

Here are some recent quotes from research analysts about Global Medical REIT stock:
  • 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (11/9/2019)
  • 2. Boenning Scattergood analysts commented, "We think that GMRE could have purchasing power remaining, on the order of $25 million to $35 million, and that incremental acquisition activity in 2019 will be funded by the newly expanded credit facility and ATM offerings. While GMRE’s portfolio acquisition offered an attractive ROI, we think that future acquisitions will be one-off properties — probably medical office – priced around its sweet spot of $10 million on average. Based on what we know about the timing of acquisitions in April and what we estimate in terms of acquisition activity over the balance of the year, we are raising our forward NAV estimate from $10.30 to $10.50." (5/10/2019)

Has Global Medical REIT been receiving favorable news coverage?

News stories about GMRE stock have been trending negative on Friday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Global Medical REIT earned a news impact score of -2.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Global Medical REIT.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest in the month of November. As of November 29th, there was short interest totalling 873,400 shares, an increase of 100.6% from the November 14th total of 435,400 shares. Based on an average trading volume of 284,600 shares, the short-interest ratio is presently 3.1 days. Currently, 2.7% of the company's stock are short sold. View Global Medical REIT's Current Options Chain.

Who are some of Global Medical REIT's key competitors?

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Insys Therapeutics (INSY), Principal Financial Group (PFG), General Electric (GE), Big Lots (BIG), Square (SQ), Cypress Semiconductor (CY), Ritter Pharmaceuticals (RTTR), Sangamo Therapeutics (SGMO), Ready Capital (RC) and AT&T (T).

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the folowing people:
  • Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
  • Danica Holley, Chief Operating Officer
  • Robert J. Kiernan, Chief Financial Officer & Treasurer
  • Alfonzo Leon, Chief Investment Officer
  • Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (1.96%), Psagot Investment House Ltd. (1.76%), Foundry Partners LLC (1.29%), State of New Jersey Common Pension Fund D (1.23%), Millennium Management LLC (0.74%) and Stifel Financial Corp (0.67%). Company insiders that own Global Medical REIT stock include Jeffrey Busch, Matthew Cypher, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.

Which institutional investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, State of New Jersey Common Pension Fund D, Goodwin Daniel L, California Public Employees Retirement System, State of Alaska Department of Revenue, Barclays PLC, ICM Asset Management Inc. WA and Strs Ohio. View Insider Buying and Selling for Global Medical REIT.

Which institutional investors are buying Global Medical REIT stock?

GMRE stock was purchased by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Stifel Financial Corp, Chicago Equity Partners LLC, Psagot Investment House Ltd., State Street Corp, Eidelman Virant Capital, Dupont Capital Management Corp and Squarepoint Ops LLC. Company insiders that have bought Global Medical REIT stock in the last two years include Jeffrey Busch, Matthew Cypher, Ronald Marston and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $12.85.

How big of a company is Global Medical REIT?

Global Medical REIT has a market capitalization of $473.78 million and generates $53.19 million in revenue each year. The company earns $13.49 million in net income (profit) each year or $0.78 on an earnings per share basis. View Additional Information About Global Medical REIT.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is http://www.globalmedicalreit.com/.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.

MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  230 (Vote Outperform)
Underperform Votes:  239 (Vote Underperform)
Total Votes:  469
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel